At Religen Labs

In ReligenDX A Life Science Company we understand the importance of diagnostic testing in contemporary medical practice as it plays a pivotal role in determining the overall course of patient treatment.

COVID19 RT PCR testing available at Religen Inc.

Results in 24 – 48 hours.

Nasopharyngeal and saliva samples are accepted.

Please call 484-534-9311


*$150 – $250 per test depending on turn around time. 

How  Can We Help You?

Order a test kit  Or Contact Us 

Who We Are

ReligenDx A Life Science Company that develops and implements new and innovative diagnostic testing. The primary objective of our testing is to identify biomarkers in order to enable and facilitate appropriate intervention and treatment at the earliest possible stages. At Religen, we believe that reliable diagnostics are the cornerstone for effective prevention, mitigation, treatment, and healing. 

Our Vision

In ReligenDX A Life Science Company,  Inspired innovations in diagnostic testing to inform, educate, and guide every patient towards optimal health.

Therapeutic Focus

Mitochondrial Disease and Dysfunction, Cardiovascular Disease, Neurodevelopmental / Neurodegenerative Disease, Genetics.

ReligenDX A Life Science Company Diagnostic tests

Learn about our current diagnostics testing

ReligenDX A Life Science Company - Mitoswab


Buccal Swab Test to analyze the Mitochondrial Electron Transport Chain Complex (ETC I, II, III, IV)

Learn more..

ReligenDX A Life Science Company - CholEfflux


Cholesterol Efflux Capacity – A Test to Analyze HDL Function

Learn more..

ReligenDX A Life Science Company - ReliExome


Whole Exome Sequencing 

Learn more..

ReligenDX A Life Science Company - MitoSeq


Mitochondrial DNA Sequencing


Learn more..

1 in 6 children in the United States were diagnosed with a Developmental Disability in 2006-2008, ranging from mild disabilities such as speech and language impairments to serious Developmental Disabilities, such as Intellectual Disabilities, Cerebral Palsy, and Autism.

5.8 Million Americans are Living with Alzheimer’s Disease.

121.5 Million Americans, or about 48.5 percent of the population, have heart or blood vessel disease.

What do these statistics have to do with Religen Dx?

Our testing directly addresses researched diagnosis of these conditions on a cellular and molecular level.  Testing at these levels allows for individualized results and treatments, leading physicians and patients towards optimal personalized health.

Get in Touch

Send a message

5110 Campus Drive, Suite #120, Plymouth Meeting, PA 19462.

Call Us: +1 484-534-9311


5110 Campus Drive, Suite # 120,
Plymouth Meeting, PA 19462
+1 484-534-9311

Follow Us